Leap Therapeutics Inc (LPTX)
NASDAQ:LPTX
Holding LPTX?
Track your performance easily

Leap Therapeutics (LPTX) Financial Statements

869 Followers

Leap Therapeutics Financial Overview

Leap Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.995; its P/E ratio is -1.87; Leap Therapeutics is scheduled to report earnings on November 14, 2024, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -21.00M$ -14.84M$ -15.33M$ -14.81M$ -43.03M
EBITDA$ -20.80M$ -14.74M$ -15.23M$ -14.70M$ -42.93M
Net Income Common Stockholders$ -20.36M$ -13.82M$ -13.70M$ -13.39M$ -41.86M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 78.48M$ 54.92M$ 80.74M$ 91.42M$ 102.04M
Total Assets$ 81.43M$ 57.96M$ 83.05M$ 95.86M$ 106.53M
Total Debt$ 482.00K$ 584.00K$ 369.00K$ 474.00K$ 577.00K
Net Debt$ -78.00M$ -54.34M$ -80.37M$ -90.94M$ -101.46M
Total Liabilities$ 15.64M$ 10.59M$ 11.04M$ 11.80M$ 78.22M
Stockholders Equity$ 65.79M$ 47.37M$ 72.01M$ 84.06M$ 28.33M
Cash Flow-
Free Cash Flow$ -13.67M$ -15.52M$ -10.49M$ -10.19M$ -12.70M
Operating Cash Flow$ -13.67M$ -15.52M$ -10.49M$ -10.19M$ -12.70M
Investing Cash Flow---$ -348.00K$ 49.32M
Financing Cash Flow$ 37.12M$ 29.00K$ -1.00K-$ -29.00K
Currency in USD

Leap Therapeutics Earnings and Revenue History

Leap Therapeutics Debt to Assets

Leap Therapeutics Cash Flow

Leap Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis